DDIT3 and diffuse large B-cell lymphoma: In a case with GC type DLBCL, the exosomal BCL6 expression was newly observed at the end of treatment even though the PET-CT showed a complete response after completion of R-CHOP, whereas the BCL6 mutation of ctDNA was decreased at the end of treatment.